Legal Representation
Attorney
Michael T. Smith
USPTO Deadlines
Next Deadline
1987 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-14)
Due Date
January 14, 2031
Grace Period Ends
July 14, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 14, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Jan 14, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Oct 28, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
Oct 28, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
Oct 2, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
Oct 2, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Oct 2, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Jun 11, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 15, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 15, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Mar 15, 2024 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
Feb 29, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
Feb 29, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Feb 6, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
Feb 6, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
Aug 22, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jun 27, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 27, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jun 7, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
May 25, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 22, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
May 22, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 22, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 22, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Mar 22, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Mar 22, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Mar 22, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 17, 2022 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Jun 16, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 10, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Acids for pharmaceutical purposes; adjuvants for medical purposes; agricultural fungicide; aluminum acetates for pharmaceutical purposes; amino acids for medical purposes; analgesics; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; antibiotic, sunburn and anti-inflammatory ointments for pharmaceutical purposes; antibiotics; antioxidant pills for medical use; antiseptics; astringents for medical purposes; bacterial culture mediums; bacterial poisons; bacterial preparations for medical purposes for researching of human illnesses; bacteriological research preparation, namely, preparations of reports for anti-tumor treatment for medical purposes; balsamic preparations for medical purposes; biological agents for the treatment of cancer; biological preparations for medical purposes for treatment of human illnesses; biological tissue cultures for medical purposes; blood for medical purposes; blood plasma; bouillons for bacteriological cultures; bronchodilating preparations; by-products of the processing of cereals for dietetic or medical purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; candy for medical purposes; candy for pharmaceutical purpose for treatment of the cough; capsules made of dendrimer-based polymers for medicinal preparations for the mouth, for pharmaceuticals purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; chemical preparations as medicines for medical purposes, namely, for anti-tumor treatment; chemical preparations for pharmaceutical purposes for the treatment of human illnesses, namely, anti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; chemico-pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; chewing gum for medical purposes; Chinese medicine nostrum for the treatment of tumors in humans; collyrium; contact lens cleaning preparations; contact lens disinfectant; contact lenses care solution; cough pastilles for pharmaceutical purposes; crystallized rock sugar for medical purposes; depuratives for the body; diagnostic biomarker reagents for medical purposes; diagnostic preparations for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; dietetic substances of low sugar and salt adapted for medical use; digestives for pharmaceutical purposes; drugs for medical purposes for treatment of human illnesses, namely, anti-tumor treatment; enzyme preparations for medical purposes; enzymes for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; eye drops; filled portable medicine cases, comprised of pharmaceuticals for treatment of human illnesses, namely, anti-tumor treatment; first-aid boxes, filled; fungicides; gelatine for medical purposes, namely, gelatin capsules sold empty; germicides; herbal teas for medicinal purposes; insect killing preparations in the nature of pesticides; insecticidal veterinary washes; insecticides; isotopes for medical purposes; media for bacteriological cultures; medical diagnosis reagent; medical probiotic supplements; medicated eye-washes; medicated lozenges for pharmaceutical purposes; medicinal drinks; medicinal hair growth preparations; medicinal preparations for the mouth to be applied in the form of capsules; medicines for alleviating constipation; medicines for dental purposes; mineral, bath and sodium salts for medical purposes; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; opotherapy preparations; organotherapy preparations; pesticides; petroleum jelly for medical purposes; pharmaceutical blood preparations, namely, a blood clotting aid and delivery system for use in human medicine; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; pharmaceutical preparations for skin care; pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; pharmaceutical preparations, namely, elixirs for anti-tumor treatment; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposes, namely, anti-tumor treatment; preparations for destroying noxious animals; protein dietary supplements; radioactive substances for medical purposes; radiological contrast substances for medical purposes; rat poison; raw material drugs, namely, pharmaceuticals for anti-tumor treatment; reagent paper for medical purposes; reagent paper for veterinary purposes; rubbing alcohol; solutions for contact lenses; stem cells for medical purposes; sterilizing preparations; styptic preparations; tonics being pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; vaccine preparations; bacteriological preparations for veterinary use; cultures of microorganisms for veterinary use; chemical reagents for veterinary purposes; veterinary preparations for the treatment of intestinal bacteria; diagnostic preparations for veterinary use
First Use Anywhere:
Dec 4, 2023
First Use in Commerce:
Dec 4, 2023
Additional Information
Design Mark
The mark consists of the literal element "ZEGFROVY" to the right of a design consisting of two pairs of differing fanciful geometric shapes intended to depict a gene mutation process.
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "ZEGFROVY" has no meaning in a foreign language.
Classification
International Classes
005